3 Stocks Estimated To Be Undervalued By Up To 48.5%

TransMedics Group +1.00% Post

TransMedics Group

TMDX

100.40

100.91

+1.00%

+0.51% Post

As U.S. stock indices reach new heights, driven by optimism surrounding U.S.-China trade talks and strong corporate earnings, investors are keenly observing the potential impacts of these developments on market valuations. In this environment of record-setting highs, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer attractive entry points relative to their intrinsic value.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est)
Udemy (UDMY) $6.81 $13.53 49.7%
Old National Bancorp (ONB) $21.05 $42.09 50%
McGraw Hill (MH) $12.70 $25.38 50%
GeneDx Holdings (WGS) $128.87 $248.76 48.2%
First Busey (BUSE) $23.48 $45.91 48.9%
Fifth Third Bancorp (FITB) $42.63 $82.74 48.5%
Dime Community Bancshares (DCOM) $27.84 $55.36 49.7%
Corpay (CPAY) $284.38 $545.71 47.9%
Constellium (CSTM) $16.90 $32.35 47.8%
Brunswick (BC) $71.91 $138.84 48.2%

Here's a peek at a few of the choices from the screener.

TransMedics Group (TMDX)

Overview: TransMedics Group, Inc. is a commercial-stage medical technology company focused on transforming organ transplant therapy for end-stage organ failure patients globally, with a market cap of $4.45 billion.

Operations: The company generates revenue primarily from its Surgical & Medical Equipment segment, amounting to $531.29 million.

Estimated Discount To Fair Value: 46.2%

TransMedics Group is trading at US$130.52, significantly below its estimated fair value of US$242.68, indicating potential undervaluation based on cash flows. The company's earnings grew substantially last year and are forecast to continue growing faster than the market average. Recent FDA approval for a major clinical trial and revised revenue guidance further highlight its growth prospects, with expected 2025 revenue between US$585 million and US$605 million, reflecting strong operational performance.

    TMDX Discounted Cash Flow as at Oct 2025
    TMDX Discounted Cash Flow as at Oct 2025

    Fifth Third Bancorp (FITB)

    Overview: Fifth Third Bancorp is the bank holding company for Fifth Third Bank, National Association, offering a variety of financial products and services across the United States with a market cap of $28.18 billion.

    Operations: Fifth Third Bancorp generates revenue through various financial products and services provided by Fifth Third Bank, National Association, across the United States.

    Estimated Discount To Fair Value: 48.5%

    Fifth Third Bancorp, trading at US$42.63, is valued below its estimated fair value of US$82.74, highlighting potential undervaluation based on cash flows. The company forecasts significant annual earnings growth of 29.45%, outpacing the market average. Recent earnings reports show increased net income and interest income year-over-year despite a US$170 million to US$200 million impairment charge due to fraud issues, which may affect short-term financials but not long-term growth prospects.

      FITB Discounted Cash Flow as at Oct 2025
      FITB Discounted Cash Flow as at Oct 2025

      Bloom Energy (BE)

      Overview: Bloom Energy Corporation designs, manufactures, sells, and installs solid-oxide fuel cell systems for on-site power generation both in the United States and internationally, with a market cap of $25.83 billion.

      Operations: The company's revenue primarily comes from its electric equipment segment, generating $1.63 billion.

      Estimated Discount To Fair Value: 32.7%

      Bloom Energy, trading at US$110.38, is undervalued with an estimated fair value of US$164.11. Forecasted revenue growth of 24.2% annually and significant earnings growth position it ahead of the market average. A strategic partnership with Brookfield involves a US$5 billion investment to advance AI infrastructure using Bloom's fuel cells, potentially enhancing cash flow prospects despite recent volatility in share price and challenges in covering interest payments through earnings alone.

        BE Discounted Cash Flow as at Oct 2025
        BE Discounted Cash Flow as at Oct 2025

        Seize The Opportunity

        • Gain an insight into the universe of 182 Undervalued US Stocks Based On Cash Flows by clicking here.
        • Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
        • Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

        Ready For A Different Approach?

        • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
        • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
        • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

        This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.